Maarten van Lohuizen

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 8

Top Topics

Dna Damage Response

Patient Reported

Top Venues

British journal of cancer

Cancer research communications

Clinical cancer research : an official journal of the American Association for Cancer Research

This page only lists publications with an associated author ORCID identifier.

Publications

Nick Landman, Danielle Hulsman, Jitendra Badhai, Jawahar Kopparam, Julian Puppe, Gaurav Kumar Pandey, Maarten van Lohuizen
Combination of EZH2 and ATM inhibition in BAP1-deficient mesothelioma. British journal of cancer (2024)
Nick Landman, Danielle Hulsman, Jitendra Badhai, Jawahar Kopparam, Julian Puppe, Gaurav Kumar Pandey, Maarten van Lohuizen
Combination of EZH2 and ATM inhibition in BAP1-deficient mesothelioma. British journal of cancer 130 (11) (2024)
Nick Landman, Danielle Hulsman, Jitendra Badhai, Jawahar Kopparam, Julian Puppe, Gaurav Kumar Pandey, Maarten van Lohuizen
Combination of EZH2 and ATM inhibition in BAP1-deficient mesothelioma. British journal of cancer 130 (11) (2024)
Nick Landman, Danielle Hulsman, Jitendra Badhai, Jawahar Kopparam, Julian Puppe, Gaurav Kumar Pandey, Maarten van Lohuizen
Combination of EZH2 and ATM inhibition in BAP1-deficient mesothelioma. British journal of cancer 130 (11) (2024)
Nick Landman, Danielle Hulsman, Jitendra Badhai, Jawahar Kopparam, Julian Puppe, Gaurav Kumar Pandey, Maarten van Lohuizen
Combination of EZH2 and ATM inhibition in BAP1-deficient mesothelioma. British journal of cancer 130 (11) (2024)
Jitendra Badhai, Nick Landman, Gaurav Kumar Pandey, Ji-Ying Song, Danielle Hulsman, Oscar Krijgsman, Gayathri Chandrasekaran, Anton Berns, Maarten van Lohuizen
Combined inhibition of EZH2 and FGFR is synergistic in BAP1- deficient malignant mesothelioma. Cancer research communications (2023)
Santiago Gisler, Ana Rita R Maia, Gayathri Chandrasekaran, Jawahar Kopparam, Maarten van Lohuizen
A genome-wide enrichment screen identifies NUMA1-loss as a resistance mechanism against mitotic cell-death induced by BMI1 inhibition. PloS one 15 (4) (2020)
Julian Puppe, Mark Opdam, Philip C Schouten, Katarzyna Jóźwiak, Esther Lips, Tesa Severson, Marieke van de Ven, Chiara Brambillasca, Peter Bouwman, Olaf van Tellingen, René Bernards, Jelle Wesseling, Christian Eichler, Fabinshy Thangarajah, Wolfram Malter, Gaurav Kumar Pandey, Luka Ozretić, Carlos Caldas, Maarten van Lohuizen, Michael Hauptmann, Kerstin Rhiem, Eric Hahnen, H Christian Reinhardt, Reinhard Büttner, Peter Mallmann, Birgid Schömig-Markiefka, Rita Schmutzler, Sabine Linn, Jos Jonkers
EZH2 Is Overexpressed in BRCA1-like Breast Tumors and Predictive for Sensitivity to High-Dose Platinum-Based Chemotherapy. Clinical cancer research : an official journal of the American Association for Cancer Research 25 (14) (2019)